Inventor · disambiguated record
Mark C. Faulkner
Also filed as: FAULKNER MARK · FAULKNER MARK C · FAULKNER MARK CARROLL
14 granted patents·11 pending applications·86 citations·filing 2004–2024
91Inventor score
Top patents by PatentIndex Score
25 records- 0194US8354450B2Creatine oral supplementation using creatine hydrochloride saltVIREO SYSTEMS INC·Filed 2010·Granted Jan 15, 2013·22 cites·20 claims
- 0291US8962685B2Creatine oral supplementation using creatine hydrochloride saltVIREO SYSTEMS INC·Filed 2013·Granted Feb 24, 2015·11 cites·20 claims
- 0390US9486424B2Creatine oral supplementation using creatine hydrochloride saltVIREO SYSTEMS INC·Filed 2015·Granted Nov 8, 2016·7 cites·16 claims
- 0490US8026385B2Creatine oral supplementation using creatine hydrochloride saltVIREO SYSTEMS INC·Filed 2009·Granted Sep 27, 2011·15 cites·7 claims
- 0587US10881630B2Creatine oral supplementation using creatine hydrochloride saltVIREO SYSTEMS INC·Filed 2019·Granted Jan 5, 2021·1 cites·20 claims
- 0687US9962352B2Creatine oral supplementation using creatine hydrochloride saltVIREO SYSTEMS INC·Filed 2016·Granted May 8, 2018·4 cites·20 claims
- 0786US10342771B2Creatine oral supplementation using creatine hydrochloride saltVIREO SYSTEMS INC·Filed 2018·Granted Jul 9, 2019·3 cites·22 claims
- 0885US7608641B2Creatine oral supplementation using creatine hydrochloride saltUNIV NEBRASKA·Filed 2004·Granted Oct 27, 2009·20 cites·7 claims
- 0982US10583105B2Compositions and methods for neuroprotection and treatment of neurodegenerationVIREO SYSTEMS INC·Filed 2019·Granted Mar 10, 2020·1 cites·19 claims
- 1079US2021205250A1Creatine oral supplementation using creatine hydrochloride saltVIREO SYSTEMS INC·Filed 2021·Application pending·0 cites
- 1177US10245245B2Compositions and methods for neuroprotection and treatment of neurodegenerationVIREO SYSTEMS INC·Filed 2016·Granted Apr 2, 2019·2 cites·18 claims
- 1271US11826334B2Antiviral therapeutic compounds and compositions for use in treatment of coronavirus and influenza virusVIREO SYSTEMS INC·Filed 2021·Granted Nov 28, 2023·0 cites·19 claims
- 1369US2025099429A1Compositions and methods for treatment of vaginal infectionsVIREO SYSTEMS INC·Filed 2024·Application pending·0 cites
- 1468US2024325470A1Parenteral delivery device and methods of useVIREO SYSTEMS INC·Filed 2024·Application pending·0 cites
- 1565US11160776B2Compositions and methods for neuroprotection and treatment of neurodegenerationVIREO SYSTEMS INC·Filed 2020·Granted Nov 2, 2021·0 cites·20 claims
- 1665US2022218644A1Method and composition for treating osteoarthritisVIREO SYSTEMS INC·Filed 2022·Application pending·0 cites
- 1765US2025017886A1Formulations and methods for increasing creatinine levels in plasma, extracellular fluid and/or intracellular compartmentsVIREO SYSTEMS INC·Filed 2024·Application pending·0 cites
- 1864US2025064766A1Compositions and methods for increasing arginine and nitric oxide levelsVIREO SYSTEMS INC·Filed 2024·Application pending·0 cites
- 1963US2015164847A1Method and composition for treating osteoarthritisVIREO SYSTEMS INC·Filed 2014·Application pending·0 cites
- 2063US2023159442A1Cellular energy compounds, compositions, and methods of use thereofVIREO SYSTEMS INC·Filed 2022·Application pending·0 cites
- 2162US12109195B2Compositions and methods for treatment of vaginal infectionsVIREO SYSTEMS INC·Filed 2021·Granted Oct 8, 2024·0 cites·15 claims
- 2257US12011469B2Parenteral delivery device and methods of useVIREO SYSTEMS INC·Filed 2018·Granted Jun 18, 2024·0 cites·18 claims
- 2357US2009004306A1Composition for treatment of diabetes and maintaining healthy blood glucose levelsPRIDEMORE HEATHER RENEE·Filed 2007·Application pending·0 cites
- 2456US2021401879A1Compositions for controlling odor and itch and methods of and devices for administering sameVIREO SYSTEMS INC·Filed 2021·Application pending·0 cites
- 2551US2011120972A1Replacement process for fluoride ion cleaningMEYER TOOL INC·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark C. Faulkner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →